Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine

Yftach Gepner; Merav Mofaz; Shay Oved; Matan Yechezkel; Keren Constantini; Nir Goldstein; Arik Eisenkraft; Erez Shmueli; Dan Yamin

doi:10.1038/s43856-022-00090-y

Communications Medicine (Mar 2022)

Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine

Yftach Gepner,
Merav Mofaz,
Shay Oved,
Matan Yechezkel,
Keren Constantini,
Nir Goldstein,
Arik Eisenkraft,
Erez Shmueli,
Dan Yamin

Affiliations

Yftach Gepner: Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, and Sylvan Adams Sports Institute, Tel-Aviv University
Merav Mofaz: Department of Industrial Engineering, Tel-Aviv University
Shay Oved: Department of Industrial Engineering, Tel-Aviv University
Matan Yechezkel: Department of Industrial Engineering, Tel-Aviv University
Keren Constantini: Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, and Sylvan Adams Sports Institute, Tel-Aviv University
Nir Goldstein: Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, and Sylvan Adams Sports Institute, Tel-Aviv University
Arik Eisenkraft: The Institute for Research in Military Medicine, the Hebrew University Faculty of Medicine
Erez Shmueli: Department of Industrial Engineering, Tel-Aviv University
Dan Yamin: Department of Industrial Engineering, Tel-Aviv University

DOI: https://doi.org/10.1038/s43856-022-00090-y
Journal volume & issue: Vol. 2, no. 1
pp. 1 – 8

Abstract

Read online

Gepner et al. undertake a prospective observational study using a chest-patch sensor to monitor cardiovascular and hemodynamic vital signs following the BNT162b2 COVID-19 (Pfizer BioNTech) vaccine. Continuous and significant changes occurred in the vital signs, including in participants who did not report any reactions.

Published in Communications Medicine

ISSN: 2730-664X (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Medicine
Website: https://www.nature.com/commsmed/

About the journal